Dr. Philip Seo

Daniel Bunker is a Rheumatologist and an Emergency Medicine provider in Washington, Washington, D.c.. Dr. Bunker is rated as an Advanced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Scleritis, Sarcoidosis, Dermatomyositis, and Necrotizing Vasculitis. Dr. Bunker is currently accepting new patients.

Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is rated as a Distinguished provider by MediFind in the treatment of Scleritis. His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis.

Dr. Ziglar is a graduate of Stony Brook University where she was a scholar member of the Phi Beta Kappa honor society. She earned her medical degree at the State University of New York, Downstate, and completed her internal medicine residency at North Shore University Hospital, New York. She completed her fellowship training for rheumatology at New York University’s Hospital for Joint Diseases, where she was recognized by medical residents with the Fellow of the Year Award for distinguished teaching.Following fellowship, Dr. Ziglar began private practice while she maintained teaching faculty appointments as Asst. Clinical Professor of Medicine at Montefiore Medical Center in New York and later at St. Joseph Regional Medical Center in New Jersey.Although Dr. Ziglar treats all types of rheumatic conditions, she has a special interest in osteoporosis and has conducted lab research focused on promoting the development of bone and cartilage cells. Her research was recognized in the form of awards and scholarships through the National Science Foundation, the National Institutes for Health, and the Howard Hughes Medical Institute. She has contributed to the Journal of Biological Chemistry and her research was presented in multiple national abstract meetings. Dr. Ziglar finds involvement in healthcare advocacy meaningful. While a member of the American College of Rheumatology’s Government Affairs Committee, she led the 2019-2022 revisions of the College’s Health Policy Statement. Dr. Ziglar is rated as a Distinguished provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Arthritis, Postmenopausal Osteoporosis, Osteoporosis, and Rheumatoid Arthritis (RA).